GLP-1 drug users need nutritional monitoring: vitamin D, B vitamins, iron, and protein deficiencies found within 12 months

GLP-1 receptor agonists are associated with inadequate protein intake, sarcopenia, and deficiencies in vitamin D, thiamine, iron, calcium, and magnesium within 12 months, yet no formal nutritional monitoring protocols exist.

Sibal, Rhea et al.·Nutrients·2025·
RPEP-135922025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

GLP-1RAs reduce caloric intake with frequent protein inadequacy and sarcopenia. Deficiencies within 12 months: vitamin D (most common), thiamine/B vitamins, iron, calcium, magnesium, potassium. No formal monitoring protocols exist despite parallel mechanisms to bariatric surgery.

Key Numbers

How They Did This

Narrative review of PubMed and Embase OVID (August 2025) with three-stage screening. Comparison to bariatric surgery nutritional monitoring guidelines.

Why This Research Matters

With millions on GLP-1 drugs for years, nutritional deficiencies could become a major public health issue. Establishing monitoring protocols now—before widespread deficiency-related complications emerge—is a preventive imperative.

The Bigger Picture

The rapid expansion of GLP-1 prescribing has outpaced safety framework development. This review draws an important parallel to bariatric surgery, where decades of experience led to mandatory nutritional monitoring—lessons that should be applied to GLP-1 therapy now.

What This Study Doesn't Tell Us

Narrative review with limited observational data. Causation vs association unclear for some deficiencies. Most data from short-term studies. Optimal monitoring protocols not yet validated for GLP-1 users.

Questions This Raises

  • ?Should baseline nutritional screening be mandatory before starting GLP-1 drugs?
  • ?Which specific supplements should be recommended for long-term GLP-1 users?
  • ?Does sarcopenia from GLP-1 drugs worsen long-term health outcomes?

Trust & Context

Key Stat:
No monitoring protocols exist Despite causing nutritional deficiencies within 12 months, GLP-1 drugs lack the mandatory nutritional monitoring established for bariatric surgery
Evidence Grade:
Narrative review of observational evidence. Highlights an important clinical gap but evidence for specific monitoring protocols is not yet established.
Study Age:
Published in 2025; literature through August 2025.
Original Title:
Macronutrient, Micronutrient Supplementation and Monitoring for Patients on GLP-1 Agonists: Can We Learn from Metabolic and Bariatric Surgery?
Published In:
Nutrients, 17(23) (2025)
Database ID:
RPEP-13592

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

Can GLP-1 drugs cause vitamin deficiencies?

Yes. This review found that GLP-1 drugs reduce caloric intake enough to cause deficiencies in vitamin D, B vitamins, iron, calcium, magnesium, and potassium within 12 months. Protein intake is often inadequate, and some patients develop muscle loss (sarcopenia). Regular blood tests and dietary counseling are recommended.

Should I take supplements while on a GLP-1 drug?

Based on this review, it may be wise to discuss with your doctor about monitoring your vitamin D, B vitamins, iron, and other nutrients. A high-protein diet is especially important to prevent muscle loss. The authors recommend adapting the nutritional monitoring used after bariatric surgery for GLP-1 patients.

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-13592·https://rethinkpeptides.com/research/RPEP-13592

APA

Sibal, Rhea; Balamurugan, G; Langley, Jasmine; Graham, Yitka; Mahawar, Kamal. (2025). Macronutrient, Micronutrient Supplementation and Monitoring for Patients on GLP-1 Agonists: Can We Learn from Metabolic and Bariatric Surgery?. Nutrients, 17(23). https://doi.org/10.3390/nu17233659

MLA

Sibal, Rhea, et al. "Macronutrient, Micronutrient Supplementation and Monitoring for Patients on GLP-1 Agonists: Can We Learn from Metabolic and Bariatric Surgery?." Nutrients, 2025. https://doi.org/10.3390/nu17233659

RethinkPeptides

RethinkPeptides Research Database. "Macronutrient, Micronutrient Supplementation and Monitoring ..." RPEP-13592. Retrieved from https://rethinkpeptides.com/research/sibal-2025-macronutrient-micronutrient-supplementation-and

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.